Company News
Eisai Targets ¥1 trn Sales, ¥90 bn Profit
Eisai presented a three‑year plan targeting FY ending March 2029 sales of ¥1 trillion and operating profit of ¥90 billion.
Product targets include ¥300 bn for Leqembi, ¥250 bn for Lenvima and ¥100 bn